STOCK-BASED COMPENSATION (Tables)

9 Months Ended

Sep. 30, 2025

Share-Based Payment Arrangement [Abstract]

Schedule of stock-based compensation expense

Stock-based compensation expense, which includes expense for both equity and liability-classified awards, reported in the condensed consolidated statements of operations, was as follows:


	Three Months Ended				Nine Months Ended
(in thousands)	September 30, 2025		September 30, 2024		September 30, 2025		September 30, 2024
Cost of screening revenue (exclusive of amortization of intangible assets)	$	271	$	400	$	1,433	$	1,321
Cost of development services revenue	—		178		17		201
Research and development	4,330		6,838		12,089		27,906
Sales and marketing	2,499		2,434		8,300		12,786
General and administrative	7,039		7,599		22,679		30,288
Stock-based compensation expense, before taxes	14,139		17,449		44,518		72,502
Related income tax benefits	(637)		(4,230)		(5,931)		(17,598)
Stock-based compensation expense, net of taxes	$	13,502	$	13,219	$	38,587	$	54,904

Schedule of restricted stock unit activity

A summary of the Company’s restricted stock unit activity, issued under the 2024 Plan and 2024 Inducement Plan, is as follows:


	Restricted Stock Units	Weighted-Average Grant-Date Fair Value Per Share
(Units in thousands)
Outstanding at January 1, 2025	5,523	$14.22
Awarded	2,370	$38.60
Released	(2,268)	$15.36
Forfeited	(518)	$21.85
Outstanding at September 30, 2025	5,107	$24.56

Schedule of ESPP fair value assumptions

The fair value of employee stock purchase rights under the ESPP have been estimated with the following assumptions using the Black-Scholes-Merton option-pricing model:


			Three and Nine Months Ended
			September 30, 2025
Weighted-average assumptions:
Expected life (in years)			0.5
Risk-free interest rate			4.2%
Expected volatility			108.7%
Expected dividend			0%
Weighted-average estimated grant date fair value per share			$17.68